MRNA-USDCon Raydium CLMMCLMMHigh Yield
- Chain
- Solana
- TVL
- TVL $70.94K
- APR
- 500.0% APR
- 24h Volume
- $156.03K 24h vol
- Fee tier
- 1.00% fee
- Pool address
- KksmWd9N…6B5m · observed 2026-10-05
new capital
keep position
urgency to leave
The Wealthville Score is 58/100, with Enter at 54/100, Hold at 64/100, and Exit at 18/100; the live verdict is HOLD. That supports monitoring an existing position rather than treating the displayed APR as a standalone entry signal, especially because the stated verdict driver is ai_engine=hold and the pool ranks #986 of 8415 raydium-clmm pools. The assessment would change if TVL drained, trading volume weakened, fee APR collapsed, MRNA volatility increased, or the position repeatedly moved out of range; sustained fee generation with stable liquidity would provide the opposite evidence.
Computed 2026-10-05 10:47 UTC from on-chain yield, liquidity-depth, and risk signals. Not financial advice.
Liquidityhelp
lock$70.94K
Total value locked
$156.03K
24h volume
Yieldhelp
trending_up500.0%
advertised APRFee yield, annualized
≈ 716.0%
adjusted · net of IL (est.)
My Position
account_balance_walletAI Verdict
Wait & Monitor
WealthVille AI evaluation verdict for this liquidity pool investment opportunity.
Use a narrow range centered on the current MRNA/USDC price, and review or remove the position when price closes outside that range or when the pool's volume-to-TVL ratio falls materially below 2.20x.
syncAI analysis is refreshing in the background
Performance Breakdown
| Metric | 24h / Day | 7d / Week | 30d / Month |
|---|---|---|---|
| Total APR | 500.0% | — | — |
| Fee APR | 500.0% | — | — |
| Volume | $156.03K | — | — |
| Fees Earned | $2.64K | — | — |
Data sourced from Raydium Protocol, Birdeye, and DexScreener. Updated every snapshot cycle.
Efficiency Metrics
ComputedDeterministic efficiency metrics computed from on-chain data for this liquidity pool. All values are calculated directly from pool analytics — not AI-generated.
Pool Rankings
#1 of 3 MRNA-USDC pools
by AI Farmer Score
#223 of 18237 on raydium-clmm
by AI Farmer Score
Top 2% of all Solana pools
overall rank #1312 of 130194
How This Pool Works
Beginner FriendlyThis page provides real-time AI analytics and performance data for the MRNA-USDC liquidity pool on Raydium CLMM. Data is sourced from on-chain Solana activity, Birdeye, DexScreener, and CoinGecko.
Providing liquidity here means depositing MRNA and USDC into a price range so traders can swap between them, with trading fees paid to liquidity providers. You can earn fees, but a large MRNA price move can leave you holding a different mix of MRNA and USDC than you deposited, and the value can fall.
Pool Analysis
trending_upYield Source Breakdown
Yield decomposes into 500.0% fee APR and 0.0% reward APR, with 100% of reported yield sourced from trading fees. Because reward APR is currently zero, the headline return depends on continued MRNA-USDC trading volume and LP fee capture rather than token emissions. The displayed APR is annualized and can fall quickly if volume or liquidity conditions change.
shieldRisk Assessment
A recent seven-day impermanent-loss reading is not available, and seven-day tick-in-range coverage is also unavailable, so recent range efficiency and realized IL cannot be quantified from these metrics. As a MEMECOIN pool, MRNA-USDC is exposed to abrupt price moves, which can push a concentrated position out of range and leave the LP holding a less balanced inventory. Emission decay is not the current yield driver because reward APR is zero, but exit timing remains important: a volume decline or sharp MRNA repricing can reduce fee income and worsen inventory exposure before an LP exits.
tollMRNA Context
MRNA is the volatile asset in this pair, while USDC provides the quoted dollar unit for the position. MRNA's liquidity depth outside this pool is not established by the supplied metrics; thin external liquidity would increase slippage and make price moves more consequential for the LP. MRNA appreciation or decline changes the pool price and can move a concentrated position out of range, while prolonged one-directional movement can increase inventory divergence.
tollUSDC Context
USDC is the stable quote asset and the accounting reference for measuring MRNA's pool price. Its broader Solana liquidity is generally deeper than that of a memecoin, but that does not remove MRNA-specific volatility or guarantee efficient exits from this pool. If MRNA falls sharply, the LP can end up with more MRNA relative to USDC; if MRNA rises sharply, the position can become more USDC-heavy after rebalancing.
lightbulbSimple Explanation
Providing liquidity here means depositing MRNA and USDC into a price range so traders can swap between them, with trading fees paid to liquidity providers. You can earn fees, but a large MRNA price move can leave you holding a different mix of MRNA and USDC than you deposited, and the value can fall.
Token Details
Pool Details
- Pool Address
- KksmWd9NZjsp7Mk3kiaWMRA1yEEmogthqvsCY5L6B5m
- Protocol
- Raydium CLMM
- Chain
- solana
- Fee Tier
- —
- Pool Type
- Concentrated Liquidity (CLMM)
- Token A
- MRNA (MRNAzXzh…)
- Token B
- USDC (EPjFWdd5…)
- Created
- 9/18/2026
Explore More
Similar Pools — Same Protocol
APR
0%
APR
0%
APR
1%
APR
0%
By Protocol
hubAll raydium-clmm poolsarrow_forwardBlockchain
dnsAll Solana poolsarrow_forwardNon-Custodial
Your funds are never held by WealthVille. All positions are on-chain.
Verified Data Sources
Raydium, Birdeye, DexScreener, CoinGecko, LlamaYield
AI-Powered Analysis
Proprietary scoring model trained on historical Solana DeFi data
⚠️ WealthVille AI analytics are for informational purposes only. APR, TVL, and AI scores are based on historical and real-time data and do not constitute financial advice. DeFi investments carry significant risk including impermanent loss and smart contract risk. Always do your own research.
Frequently Asked Questions
Emission decay is not currently reducing the displayed reward component because 0.0% is the reward APR. The current 500.0% therefore depends on 500.0% in trading fees, although future emissions or their absence could change the mix.
Emission decay is not currently reducing the displayed reward component because 0.0% is the reward APR. The current 500.0% therefore depends on 500.0% in trading fees, although future emissions or their absence could change the mix.
This pool currently shows 0.0% reward APR, so there is no displayed farm-emission contribution to remove. If incentives are introduced and later expire, the remaining return would depend on trading fees, currently represented by 500.0% and supported by 100% fee sustainability.
This pool currently shows 0.0% reward APR, so there is no displayed farm-emission contribution to remove. If incentives are introduced and later expire, the remaining return would depend on trading fees, currently represented by 500.0% and supported by 100% fee sustainability.
Risk is high relative to a stable or major-token pair because MRNA can move sharply and concentrated liquidity can leave its active range. The pool's $71K TVL and 2.20x volume-to-TVL ratio indicate active turnover, but they do not cap price risk or guarantee an orderly exit.
Risk is high relative to a stable or major-token pair because MRNA can move sharply and concentrated liquidity can leave its active range. The pool's $71K TVL and 2.20x volume-to-TVL ratio indicate active turnover, but they do not cap price risk or guarantee an orderly exit.
Consider exiting when MRNA closes outside your selected range, when volume falls enough that fee income no longer justifies the exposure, or when TVL begins draining. For this pool, compare current activity with 2.20x and do not rely on 500.0% remaining constant.
Consider exiting when MRNA closes outside your selected range, when volume falls enough that fee income no longer justifies the exposure, or when TVL begins draining. For this pool, compare current activity with 2.20x and do not rely on 500.0% remaining constant.
There is no reliable break-even estimate because recent impermanent-loss history is unavailable and future volume, price paths, and range management are unknown. Fees are reported at 500.0%, but that annualized figure cannot establish how long recovery would take after a large MRNA move.
There is no reliable break-even estimate because recent impermanent-loss history is unavailable and future volume, price paths, and range management are unknown. Fees are reported at 500.0%, but that annualized figure cannot establish how long recovery would take after a large MRNA move.
